Cancer Cell Fusion and Post-Hybrid Selection Process (PHSP)

Area of Science:

• Oncology
• Cell Biology
• Cancer Research

Background:

• Cancer cell fusion (homotypic or heterotypic) is an infrequent event with questionable clinical relevance.
• Despite rarity, cancer cell fusion can promote tumor growth and metastasis.
• Hybrid cells formed via fusion require a post-hybrid selection process (PHSP) to manage genomic instability and metabolic functions.

Purpose of the Study:

• To review the mechanisms underlying the post-hybrid selection process (PHSP) in cancer hybrid cells.
• To explore the functional alterations and new properties of cancer hybrid cells.
• To discuss the clinical consequences and therapeutic challenges arising from fusion-induced tumor heterogeneity.

Main Methods:

• Literature review focusing on mechanisms of cancer cell fusion and post-hybrid selection.
• Analysis of functional alterations and genomic instability in cancer hybrid cells.
• Discussion of therapeutic implications and potential strategies involving mesenchymal stromal cells (MSCs).

Main Results:

• Cancer cell fusion leads to hybrid cells that undergo a PHSP to ensure survival and functionality.
• The PHSP addresses genomic instability and reorganizes metabolic processes in hybrid cells.
• Cancer hybrid cells exhibit new properties contributing to tumor heterogeneity and therapeutic resistance.

Conclusions:

• Cancer cell fusion, while rare, significantly impacts tumor progression and heterogeneity.
• Understanding PHSP mechanisms is critical for addressing therapeutic challenges posed by cancer hybrids.
• Mesenchymal stromal cells (MSCs) and their exosomes offer potential as vehicles for targeted anti-cancer therapies.